Why is Oxygenta Pharma falling/rising?

As of 15-Oct, Oxygenta Pharmaceutical Ltd is experiencing a price increase, currently at Rs 59.82, reflecting a rise of 2.84 (4.98%). The stock has shown a positive performance today, outperforming its sector by 4.9% and has gained consecutively over the last two days, accumulating a total return of 6.12% in this period. Despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 50.43% against the 5-day average, indicating growing interest in the stock.
In the broader market context, Oxygenta Pharma's short-term performance contrasts sharply with the benchmark, as it has declined by 7.31% over the past week while the Sensex has increased by 1.02%. Over the past month, the stock has fallen by 14.54%, compared to a slight gain of 1.00% for the Sensex. Year-to-date, Oxygenta has seen a significant decline of 31.61%, while the benchmark has risen by 5.72%. This divergence highlights the challenges faced by Oxygenta Pharma despite its recent gains, as it continues to lag behind the broader market trends.